Published in Hepatitis Weekly, December 8th, 2008
"An in vitro HSC model was designed by using a previously described RI-T cell line stimulated by transforming growth factor-beta 1 (TGF-beta 1)....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.